Position Responsibilities
- Oversee and lead all accounting operations activities including consolidations involving multiple subsidiaries, monthly close processes, intercompany, payroll and equity.
- Help to build and scale accounting operations team, including creating processes to enable timely closing procedures that are scalable for growth
- Ensure strong internal control environment is maintained
- Assist in setting up policies related to travel and transparency reporting;
- Position will also require partnership with various members of cross functional teams
- Ability to capitalize on team member strengths and raise the team as a whole
- Assist in ad-hoc projects as needed
Candidate Requirements
- Bachelor’s degree in business, Accounting, or Finance
- CPA and/or MBA preferred
- Hands-on knowledge of accounting operations and processes
- Prior management of an accounting team
- Excellent communication and relationship building skills
- Familiarity with internal controls requirements in a public company
- Strong organizational and problem-solving skills with the ability to manage multiple projects at one time
- Thrives in a dynamic environment
- Ability to work effectively with cross-functional teams
- At least 10 years of applicable experience in a pharmaceutical or biotechnology environment with prior experience in a public company
- Experience with Netsuite and/or SAP a plus
Top Skills
What We Do
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role. Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn. For additional information on our guidelines, please visit https://scholarrock.com/community-guidelines/ For more information on how Scholar Rock collects, uses, and shares personal information, please visit: https://scholarrock.com/privacy-policy






